Acquiring Company
CORONA Remedies Limited
Acquired Company
Wokadine®
IndiaIndiaManufacturingBiotechnologyHealth CarePharmaceuticalManufacturingBiotechnologyHealth CareMedical DeviceDescription
CORONA Remedies Limited has successfully acquired the Wokadine® brand from Dr. Reddy's Laboratories, effective March 30, 2026. This marks CORONA's fifth acquisition and a strategic entry into the INR 648 Cr Povidone Iodine market. Wokadine®'s legacy and expansive product range are set to enhance CORONA's pharmaceutical portfolio significantly. The acquisition aims to deepen market penetration through CORONA's extensive distribution network.
Quick answer
CORONA Remedies Limited is acquiring Wokadine®, announced March 31, 2026. CORONA Remedies Limited is based in India.
- How much did CORONA Remedies Limited pay for Wokadine®?
- The deal value was not disclosed.
- What does CORONA Remedies Limited do?
- CORONA Remedies Limited is an India-focused pharmaceutical formulation company established in 2004.
- Where are CORONA Remedies Limited and Wokadine® based?
- CORONA Remedies Limited is based in India. Wokadine® is based in India.
- Who are the decision-makers at CORONA Remedies Limited?
- Fundz holds 2 contacts at CORONA Remedies Limited. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Other recent acquisitions in Pharmaceutical and Medical Device
Deals where the buyer or target shares a sector with this one, within 45 days, from Fundz verified event records.
- ESTEVE acquires TerSera's Infusion Business Unit (May 4, 2026)
- Oury Medical acquires Céfiméca for growth strategy (April 6, 2026)
- Embecta to acquire Owen Mumford Holdings Limited (March 19, 2026)
- Kopran Limited to merge with Kopran Laboratories Limited (February 27, 2026)
- Assertio acquires Garda Therapeutics in merger deal (May 5, 2026)
- Advanced Bifurcation Systems Acquires Svelte Medical (April 27, 2026)
Who to call at CORONA Remedies Limited, and when
When CORONA Remedies Limited changes hands, the new owners review vendors, systems and leadership. That is when the door opens.
- An alert the day CORONA Remedies Limited raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at CORONA Remedies Limited, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at CORONA Remedies Limited. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment CORONA Remedies Limited makes an acquisition, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Frequently asked
Who acquired Wokadine®?
Wokadine® was acquired by CORONA Remedies Limited, based in India. The deal was reported on March 31, 2026. CORONA Remedies Limited is an India-focused pharmaceutical formulation company established in 2004. CORONA Remedies Limited is privately held and operates in Manufacturing.
When did CORONA Remedies Limited acquire Wokadine®?
CORONA Remedies Limited's acquisition of Wokadine® was reported on March 31, 2026. CORONA Remedies Limited has successfully acquired the Wokadine® brand from Dr. Reddy's Laboratories, effective March 30, 2026. This marks CORONA's fifth acquisition and a strategic entry into the INR 648 Cr Povidone Iodine market. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.
What does Wokadine® do?
Wokadine® is a well-established brand in the Povidone Iodine market, recognized for its extensive product range designed for various medical applications. It is privately held, operating in Manufacturing, and is based in India.
This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.